Momenta Pharmaceuticals

After spending $6.5B for Momenta, J&J readies 'pipeline in a product' for pivotal year
Fierce Biotech
Mon, 02/27/23 - 10:09 am
JNJ
Janssen
nipocalimab
Momenta Pharmaceuticals
J&J's Momenta calls infringement against Viatris' Copaxone generic, but why now?
Fierce Pharma
Thu, 05/26/22 - 10:46 am
JNJ
Momenta Pharmaceuticals
Viatris
Copaxone
generics
drug manufacturing
The top 10 largest biopharma M&A deals in 2020
Fierce Pharma
Tue, 01/19/21 - 10:30 am
M&A
AstraZeneca
Alexion
Bristol-Myers Squibb
MyoKardia
Gilead Sciences
Forty Seven
Merck
VelosBio
Nestle
Aimmune
Immunomedics
JNJ
Momenta Pharmaceuticals
Sanofi
Principia Biopharma
Bayer
Asklepios BioPharmaeutical
Gilead rescues biopharma’s takeout scene
EP Vantage
Wed, 10/7/20 - 11:02 am
M&A
Gilead Sciences
Immunomedics
JNJ
Momenta Pharmaceuticals
Sanofi
Principia Biopharma
Nestle
Aimmune
Tizona Therapeutics
J&J, free from rival bidders, made Momenta wait on $6.5B deal
Fierce Biotech
Thu, 09/3/20 - 10:07 am
JNJ
Momenta Pharmaceuticals
M&A
J&J inks $6.5B Momenta buyout to bag autoimmune drug
Fierce Biotech
Wed, 08/19/20 - 11:06 am
JNJ
Momenta Pharmaceuticals
M&A
myasthenia gravis
2 Biotechs Battling Immune Diseases
Motley Fool
Sun, 01/19/20 - 07:41 pm
Rigel Pharmaceuticals
Momenta Pharmaceuticals
autoimmune disease
biologics
small molecule drugs
Momenta Continues to Rebuild
Motley Fool
Thu, 02/28/19 - 09:14 pm
Momenta Pharmaceuticals
earnings
AbbVie staves off 6th Humira biosimilar in US
Biopharma Dive
Wed, 11/7/18 - 10:44 pm
AbbVie
Humira
biosimilars
Momenta Pharmaceuticals
Here's Why Momenta Pharmaceuticals Tumbled 13.5% on Friday
Motley Fool
Fri, 10/12/18 - 11:40 pm
Momenta Pharmaceuticals
Teva Pharmaceuticals
Copaxone
Novartis
biosimilars
Glatopa
Momenta starts countdown to biosimilars exit
EP Vantage
Mon, 10/1/18 - 02:55 pm
Momenta Pharmaceuticals
Mylan
biosimilars
Momenta Pharmaceuticals Contemplates Its Future
Motley Fool
Tue, 05/15/18 - 09:26 pm
Momenta Pharmaceuticals
earnings
Momenta Pharmaceuticals Wraps Up a Bleak Year
Motley Fool
Fri, 02/23/18 - 07:56 am
Momenta Pharmaceuticals
earnings
biosimilars
generics
Novartis, Momenta grab a delayed FDA OK for blockbuster Copaxone knockoff
Endpoints
Tue, 02/13/18 - 09:11 am
Novartis
Momenta Pharmaceuticals
FDA
Copaxone
Teva Pharmaceutical
Glatopa
MS
multiple sclerosis
Pfizer's manufacturing fix clears path for Momenta's Copaxone generic
Biopharma Dive
Thu, 02/1/18 - 09:45 pm
Pfizer
drug manufacturing
generics
Momenta Pharmaceuticals
Copaxone
Novartis
Mylan, Momenta take aim at Regeneron’s Eylea with biosimilar
Drug Delivery Business News
Thu, 01/4/18 - 11:01 am
Mylan Labs
Momenta Pharmaceuticals
Regeneron
Eylea
biosimilars
diabetic macular edema
wet age-related macular degeneration
M710
Momenta Pharmaceuticals, Inc.'s Rough Month
Motley Fool
Fri, 11/10/17 - 10:18 pm
Momenta Pharmaceuticals
earning
Momenta's Supply Partner Gets FDA Warning
Investopedia
Tue, 02/21/17 - 11:30 am
Momenta Pharmaceuticals
FDA
warnings
Glatopa
drug manufacturing
Momenta’s failed pancreatic cancer drug is given a midnight funeral
Endpoints
Fri, 09/2/16 - 09:39 am
Momenta Pharmaceuticals
pancreatic cancer
necuparanib
Why Momenta Pharmaceuticals Shares Made a Late-Day Jump Higher
Motley Fool
Wed, 08/24/16 - 05:40 pm
Momenta Pharmaceuticals
Teva Pharmaceutical
Copaxone
patents
Mylan Labs
multiple sclerosis
MS